Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 382

1.

Genomic signatures of heterokaryosis in the oomycete pathogen Bremia lactucae.

Fletcher K, Gil J, Bertier LD, Kenefick A, Wood KJ, Zhang L, Reyes-Chin-Wo S, Cavanaugh K, Tsuchida C, Wong J, Michelmore R.

Nat Commun. 2019 Jun 14;10(1):2645. doi: 10.1038/s41467-019-10550-0.

2.

Transiently Activated Human Regulatory T Cells Upregulate BCL-XL Expression and Acquire a Functional Advantage in vivo.

Issa F, Milward K, Goto R, Betts G, Wood KJ, Hester J.

Front Immunol. 2019 Apr 24;10:889. doi: 10.3389/fimmu.2019.00889. eCollection 2019.

3.

Defining the structural basis for human alloantibody binding to human leukocyte antigen allele HLA-A*11:01.

Gu Y, Wong YH, Liew CW, Chan CEZ, Murali TM, Yap J, Too CT, Purushotorman K, Hamidinia M, El Sahili A, Goh ATH, Teo RZC, Wood KJ, Hanson BJ, Gascoigne NRJ, Lescar J, Vathsala A, MacAry PA.

Nat Commun. 2019 Feb 21;10(1):893. doi: 10.1038/s41467-019-08790-1.

4.

Immune Tolerance and Rejection in Organ Transplantation.

Stolp J, Zaitsu M, Wood KJ.

Methods Mol Biol. 2019;1899:159-180. doi: 10.1007/978-1-4939-8938-6_12. Review.

PMID:
30649772
5.

Isolation of Human Regulatory T Lymphocytes by Fluorescence-Activated Cell Sorting.

Milward K, Hester J, Wood KJ.

Methods Mol Biol. 2019;1899:43-54. doi: 10.1007/978-1-4939-8938-6_4.

PMID:
30649764
6.

The Calcineurin Inhibitor Tacrolimus Specifically Suppresses Human T Follicular Helper Cells.

Wallin EF, Hill DL, Linterman MA, Wood KJ.

Front Immunol. 2018 May 31;9:1184. doi: 10.3389/fimmu.2018.01184. eCollection 2018.

7.

National Institutes of Health Funding for Tobacco Control: 2006 and 2016.

Merianos AL, Gordon JS, Wood KJ, Mahabee-Gittens EM.

Am J Health Promot. 2019 Feb;33(2):279-284. doi: 10.1177/0890117118779013. Epub 2018 May 30.

8.

Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization.

Fuchs A, Gliwiński M, Grageda N, Spiering R, Abbas AK, Appel S, Bacchetta R, Battaglia M, Berglund D, Blazar B, Bluestone JA, Bornhäuser M, Ten Brinke A, Brusko TM, Cools N, Cuturi MC, Geissler E, Giannoukakis N, Gołab K, Hafler DA, van Ham SM, Hester J, Hippen K, Di Ianni M, Ilic N, Isaacs J, Issa F, Iwaszkiewicz-Grześ D, Jaeckel E, Joosten I, Klatzmann D, Koenen H, van Kooten C, Korsgren O, Kretschmer K, Levings M, Marek-Trzonkowska NM, Martinez-Llordella M, Miljkovic D, Mills KHG, Miranda JP, Piccirillo CA, Putnam AL, Ritter T, Roncarolo MG, Sakaguchi S, Sánchez-Ramón S, Sawitzki B, Sofronic-Milosavljevic L, Sykes M, Tang Q, Vives-Pi M, Waldmann H, Witkowski P, Wood KJ, Gregori S, Hilkens CMU, Lombardi G, Lord P, Martinez-Caceres EM, Trzonkowski P.

Front Immunol. 2018 Jan 15;8:1844. doi: 10.3389/fimmu.2017.01844. eCollection 2017.

9.

TNFR2: The new Treg switch?

Cohen JL, Wood KJ.

Oncoimmunology. 2017 Sep 21;7(1):e1373236. doi: 10.1080/2162402X.2017.1373236. eCollection 2017.

10.

Dual- and Polytobacco/Nicotine Product Use Trends in a National Sample of High School Students.

Merianos AL, Mancuso TF, Gordon JS, Wood KJ, Cimperman KA, Mahabee-Gittens EM.

Am J Health Promot. 2018 Jun;32(5):1280-1290. doi: 10.1177/0890117117743361. Epub 2017 Nov 26.

11.

Selective blockade of CD28 on human T cells facilitates regulation of alloimmune responses.

Zaitsu M, Issa F, Hester J, Vanhove B, Wood KJ.

JCI Insight. 2017 Oct 5;2(19). pii: 89381. doi: 10.1172/jci.insight.89381.

12.

Enhancing human regulatory T cells in vitro for cell therapy applications.

Milward KF, Wood KJ, Hester J.

Immunol Lett. 2017 Oct;190:139-147. doi: 10.1016/j.imlet.2017.08.012. Epub 2017 Aug 18. Review.

PMID:
28823885
13.

IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.

Jordan SC, Lorant T, Choi J, Kjellman C, Winstedt L, Bengtsson M, Zhang X, Eich T, Toyoda M, Eriksson BM, Ge S, Peng A, Järnum S, Wood KJ, Lundgren T, Wennberg L, Bäckman L, Larsson E, Villicana R, Kahwaji J, Louie S, Kang A, Haas M, Nast C, Vo A, Tufveson G.

N Engl J Med. 2017 Aug 3;377(5):442-453. doi: 10.1056/NEJMoa1612567. Erratum in: N Engl J Med. 2017 Oct 26;377(17 ):1700.

14.

Editorial: Transplant Rejection and Tolerance-Advancing the Field through Integration of Computational and Experimental Investigation.

Raimondi G, Wood KJ, Perelson AS, Arciero JC.

Front Immunol. 2017 May 30;8:616. doi: 10.3389/fimmu.2017.00616. eCollection 2017. No abstract available.

15.

Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry.

Juvet SC, Moshkelgosha S, Sanderson S, Hester J, Wood KJ, Bushell A.

J Vis Exp. 2017 Apr 19;(122). doi: 10.3791/55283.

16.

Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study.

Bottomley MJ, Chen M, Fuggle S, Harden PN, Wood KJ.

Transplant Direct. 2016 Dec 21;3(1):e125. doi: 10.1097/TXD.0000000000000638. eCollection 2017 Jan.

17.

CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression.

Arroyo Hornero R, Betts GJ, Sawitzki B, Vogt K, Harden PN, Wood KJ.

Transplantation. 2017 Feb;101(2):302-309. doi: 10.1097/TP.0000000000001278.

18.

How to Escape the Immune Response: What Tumors Teach to Transplant Physicians/Immunologists.

Claisse G, Thaunat O, Mousson C, Wood KJ, Rifle G, Mariat C.

Transplantation. 2017 Dec;101(12):2825-2829. doi: 10.1097/TP.0000000000001639. Review.

PMID:
28072758
19.

B Cells and Antibodies in Transplantation.

Koenig A, Mariat C, Mousson C, Wood KJ, Rifle G, Thaunat O.

Transplantation. 2016 Jul;100(7):1460-4. doi: 10.1097/TP.0000000000001069.

PMID:
26845305
20.

Understanding Stem Cell Immunogenicity in Therapeutic Applications.

Wood KJ, Issa F, Hester J.

Trends Immunol. 2016 Jan;37(1):5-16. doi: 10.1016/j.it.2015.11.005. Epub 2015 Dec 11. Review.

PMID:
26687737
21.

Quantification of CD4(+) T Cell Alloreactivity and Its Control by Regulatory T Cells Using Time-Lapse Microscopy and Immune Synapse Detection.

Juvet SC, Sanderson S, Hester J, Wood KJ, Bushell A.

Am J Transplant. 2016 May;16(5):1394-407. doi: 10.1111/ajt.13607. Epub 2016 Jan 29.

22.

CD8+ Immunosenescence Predicts Post-Transplant Cutaneous Squamous Cell Carcinoma in High-Risk Patients.

Bottomley MJ, Harden PN, Wood KJ.

J Am Soc Nephrol. 2016 May;27(5):1505-15. doi: 10.1681/ASN.2015030250. Epub 2015 Nov 12.

23.

Regulatory T cells: first steps of clinical application in solid organ transplantation.

van der Net JB, Bushell A, Wood KJ, Harden PN.

Transpl Int. 2016 Jan;29(1):3-11. doi: 10.1111/tri.12608. Epub 2015 Jun 3. Review.

24.

Novel biomarkers and functional assays to monitor cell-therapy-induced tolerance in organ transplantation.

Mastoridis S, Issa F, Wood KJ.

Curr Opin Organ Transplant. 2015 Feb;20(1):64-71. doi: 10.1097/MOT.0000000000000154. Review.

PMID:
25563993
25.

How postdocs benefit from building a union.

Cain B, Budke JM, Wood KJ, Sweeney NT, Schwessinger B.

Elife. 2014 Nov 21;3. doi: 10.7554/eLife.05614. No abstract available.

26.

Alloreactive regulatory T cells generated with retinoic acid prevent skin allograft rejection.

Moore C, Tejon G, Fuentes C, Hidalgo Y, Bono MR, Maldonado P, Fernandez R, Wood KJ, Fierro JA, Rosemblatt M, Sauma D, Bushell A.

Eur J Immunol. 2015 Feb;45(2):452-63. doi: 10.1002/eji.201444743. Epub 2014 Dec 2.

27.

The potential role for regulatory T-cell therapy in vascularized composite allograft transplantation.

Issa F, Wood KJ.

Curr Opin Organ Transplant. 2014 Dec;19(6):558-65. doi: 10.1097/MOT.0000000000000139. Review.

PMID:
25333829
28.

Bridging innate with adaptive immunity in transplantation: triggers, sensors, and modulators.

Wood KJ, Mariat C, Thaunat O, Mousson C, Rifle G.

Transplantation. 2014 Nov 27;98(10):1021-4. doi: 10.1097/TP.0000000000000427.

PMID:
25286058
29.

Demethylation of the TSDR is a marker of squamous cell carcinoma in transplant recipients.

Sherston SN, Vogt K, Schlickeiser S, Sawitzki B, Harden PN, Wood KJ.

Am J Transplant. 2014 Nov;14(11):2617-22. doi: 10.1111/ajt.12899. Epub 2014 Sep 23.

30.

Long-term, large scale cryopreservation of insect cells at -80 °C.

Vyletova L, Rennalls LP, Wood KJ, Good VM.

Cytotechnology. 2016 Mar;68(2):303-11. doi: 10.1007/s10616-014-9781-5. Epub 2014 Aug 23.

31.

Tolerance: one transplant for life.

Kawai T, Leventhal J, Madsen JC, Strober S, Turka LA, Wood KJ.

Transplantation. 2014 Jul 27;98(2):117-21. doi: 10.1097/TP.0000000000000260.

32.

B cells with immune-regulating function in transplantation.

Stolp J, Turka LA, Wood KJ.

Nat Rev Nephrol. 2014 Jul;10(7):389-97. doi: 10.1038/nrneph.2014.80. Epub 2014 May 20. Review.

PMID:
24846332
33.

Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning.

Juvet SC, Whatcott AG, Bushell AR, Wood KJ.

Am J Transplant. 2014 Apr;14(4):750-63. doi: 10.1111/ajt.12647. Epub 2014 Mar 4. Review.

34.

The role of donor-specific HLA alloantibodies in liver transplantation.

O'Leary JG, Demetris AJ, Friedman LS, Gebel HM, Halloran PF, Kirk AD, Knechtle SJ, McDiarmid SV, Shaked A, Terasaki PI, Tinckam KJ, Tomlanovich SJ, Wood KJ, Woodle ES, Zachary AA, Klintmalm GB.

Am J Transplant. 2014 Apr;14(4):779-87. doi: 10.1111/ajt.12667. Epub 2014 Mar 1.

35.

Examination of serum miRNA levels in kidney transplant recipients with acute rejection.

Betts G, Shankar S, Sherston S, Friend P, Wood KJ.

Transplantation. 2014 Feb 27;97(4):e28-30. doi: 10.1097/01.TP.0000441098.68212.de. No abstract available.

PMID:
24531825
36.

Induction of transplantation tolerance through regulatory cells: from mice to men.

Ferrer IR, Hester J, Bushell A, Wood KJ.

Immunol Rev. 2014 Mar;258(1):102-16. doi: 10.1111/imr.12158. Review.

PMID:
24517428
37.

Predictors of cancer risk in the long-term solid-organ transplant recipient.

Sherston SN, Carroll RP, Harden PN, Wood KJ.

Transplantation. 2014 Mar 27;97(6):605-11. doi: 10.1097/01.TP.0000436907.56425.5c. Review.

PMID:
24202142
38.

Microcephaly models in the developing zebrafish retinal neuroepithelium point to an underlying defect in metaphase progression.

Novorol C, Burkhardt J, Wood KJ, Iqbal A, Roque C, Coutts N, Almeida AD, He J, Wilkinson CJ, Harris WA.

Open Biol. 2013 Oct 23;3(10):130065. doi: 10.1098/rsob.130065.

39.

Single cell tracking of gadolinium labeled CD4+ T cells by laser ablation inductively coupled plasma mass spectrometry.

Managh AJ, Edwards SL, Bushell A, Wood KJ, Geissler EK, Hutchinson JA, Hutchinson RW, Reid HJ, Sharp BL.

Anal Chem. 2013 Nov 19;85(22):10627-34. doi: 10.1021/ac4022715. Epub 2013 Oct 3.

PMID:
24080112
40.

Ischemia-reperfusion injury accelerates human antibody-mediated transplant vasculopathy.

Goto R, Issa F, Heidt S, Taggart D, Wood KJ.

Transplantation. 2013 Jul 27;96(2):139-45.

PMID:
24049808
41.

Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model.

Fishman JM, Lowdell MW, Urbani L, Ansari T, Burns AJ, Turmaine M, North J, Sibbons P, Seifalian AM, Wood KJ, Birchall MA, De Coppi P.

Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14360-5. doi: 10.1073/pnas.1213228110. Epub 2013 Aug 12.

42.

A shift towards pro-inflammatory CD16+ monocyte subsets with preserved cytokine production potential after kidney transplantation.

Vereyken EJ, Kraaij MD, Baan CC, Rezaee F, Weimar W, Wood KJ, Leenen PJ, Rowshani AT.

PLoS One. 2013 Jul 29;8(7):e70152. doi: 10.1371/journal.pone.0070152. Print 2013.

43.

Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model.

Wu DC, Hester J, Nadig SN, Zhang W, Trzonkowski P, Gray D, Hughes S, Johnson P, Wood KJ.

Transplantation. 2013 Oct 27;96(8):707-16. doi: 10.1097/TP.0b013e31829fa271.

44.

Ischemia-reperfusion injury accelerates human antibody-mediated transplant vasculopathy.

Goto R, Issa F, Heidt S, Taggart D, Wood KJ.

Transplantation. 2013 Jul 27;96(2):139-45. doi: 10.1097/TP.0b013e318295ee32.

45.

A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen.

Kinnear G, Wood KJ, Fallah-Arani F, Jones ND.

J Immunol. 2013 Aug 1;191(3):1465-75. doi: 10.4049/jimmunol.1300553. Epub 2013 Jul 1.

46.

Cell mediated rejection.

Wood KJ, Zaitsu M, Goto R.

Methods Mol Biol. 2013;1034:71-83. doi: 10.1007/978-1-62703-493-7_3.

PMID:
23775731
47.

Cross-validation of IFN-γ Elispot assay for measuring alloreactive memory/effector T cell responses in renal transplant recipients.

Bestard O, Crespo E, Stein M, Lúcia M, Roelen DL, de Vaal YJ, Hernandez-Fuentes MP, Chatenoud L, Wood KJ, Claas FH, Cruzado JM, Grinyó JM, Volk HD, Reinke P.

Am J Transplant. 2013 Jul;13(7):1880-90. doi: 10.1111/ajt.12285. Epub 2013 Jun 13.

48.

Delayed anti-CD3 therapy results in depletion of alloreactive T cells and the dominance of Foxp3+ CD4+ graft infiltrating cells.

Goto R, You S, Zaitsu M, Chatenoud L, Wood KJ.

Am J Transplant. 2013 Jul;13(7):1655-64. doi: 10.1111/ajt.12272. Epub 2013 Jun 10.

49.

Mesenchymal stromal cells in transplantation rejection and tolerance.

English K, Wood KJ.

Cold Spring Harb Perspect Med. 2013 May 1;3(5):a015560. doi: 10.1101/cshperspect.a015560. Review.

50.

Mesenchymal stromal cells; role in tissue repair, drug discovery and immune modulation.

English K, Mahon BP, Wood KJ.

Curr Drug Deliv. 2014;11(5):561-71. Review.

PMID:
23517624

Supplemental Content

Support Center